SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway

SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway

Abstract Background As the tissue with the highest selenium content in the body, the occurrence and development of thyroid cancer are closely related to selenium and selenoproteins. Selenium-binding protein 1 (SBP1) has been repeatedly implicated in several cancers, but its role and molecular mechan...

Full description

Bibliographic Details
Main Authors:	Jiancang Ma, Xin Huang, Jinkai Xu, Zongyu Li, Jingyue Lai, Yawei Shen, Jun Zhao, Xuejun Sun, Lieting Ma
Format:	Article
Language:	English
Published:	BMC 2023-09-01
Series:	Molecular Medicine
Subjects:	Thyroid cancer Selenium-binding protein1 Thioredoxin Differentiation Sodium/iodide symporter
Online Access:	https://doi.org/10.1186/s10020-023-00700-y

Similar Items

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
by: Jierui Liu, et al.
Published: (2019-09-01)

Seaweed and Iodine Intakes and rs77277498 in Relation to Thyroid Cancer
by: Tung Hoang, et al.
Published: (2022-06-01)

Evaluation of the diphenyl herbicide, oxyfluorfen, for effects on thyroid hormones in the juvenile rat
by: T.E. Stoker, et al.
Published: (2024-01-01)

Prevalence of Thyroid Disorders in and around Nalgonda District, Telangana, India: A Cross-sectional Study
by: Pullaiah Akinepalli, et al.
Published: (2023-01-01)

Exogenous Melatonin Protects against Oxidative Damage to Membrane Lipids Caused by Some Sodium/Iodide Symporter Inhibitors in the Thyroid
by: Aleksandra K. Gładysz, et al.
Published: (2023-08-01)

Transcription Factor CREB3L1 Regulates the Expression of the Sodium/Iodide Symporter (NIS) in Rat Thyroid Follicular Cells
by: Pablo Di Giusto, et al.
Published: (2022-04-01)

Selective sodium iodide symporter (NIS) gene therapy of glioblastoma mediated by EGFR-targeted lipopolyplexes
by: Rebekka Spellerberg, et al.
Published: (2021-12-01)

Tunicamycin as a Novel Redifferentiation Agent in Radioiodine Therapy for Anaplastic Thyroid Cancer
by: Yoon Ju Choi, et al.
Published: (2021-01-01)

Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model
by: Kensuke Suzuki, et al.
Published: (2022-08-01)

Targeted Next-Generation Sequencing of Congenital Hypothyroidism-Causative Genes Reveals Unexpected Thyroglobulin Gene Variants in Patients with Iodide Transport Defect
by: Carlos Eduardo Bernal Barquero, et al.
Published: (2022-08-01)

Research Progress on Pathogenic Factors of Breast Cancer Combined with Thyroid Cancer
by: JIANG Huan, et al.
Published: (2021-05-01)

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers
by: Ji Min Oh, et al.
Published: (2022-03-01)

Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway
by: Nan-Fang Luo, et al.
Published: (2024-03-01)

Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
by: Hutzen Brian, et al.
Published: (2012-11-01)

Sinomenine Hydrochloride Promotes TSHR-Dependent Redifferentiation in Papillary Thyroid Cancer
by: Jing Zhang, et al.
Published: (2022-09-01)

Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
by: June-Key Chung, et al.
Published: (2014-09-01)

A novel strategy of transferring NIS protein to cells using extracellular vesicles leads to increase in iodine uptake and cytotoxicity
by: Son SH, et al.
Published: (2019-03-01)

Propensity Score-Matched Analysis to Identify Pathways Associated with Loss of Sodium Iodide Symporter in Papillary Thyroid Cancer
by: Fang Lee, et al.
Published: (2022-03-01)

Cancer imaging and therapy utilizing a novel NIS-expressing adenovirus: The role of adenovirus death protein deletion
by: Matthew Glen Robertson, et al.
Published: (2021-03-01)

Overexpression of Both Human Sodium Iodide Symporter (NIS) and BRG1-Bromodomain Synergistically Enhances Radioiodine Sensitivity by Stabilizing p53 through NPM1 Expression
by: Juri Na, et al.
Published: (2023-02-01)

The sodium iodide symporter (NIS) as theranostic gene: its emerging role in new imaging modalities and non-viral gene therapy
by: Carolin Kitzberger, et al.
Published: (2022-05-01)

Radio-Iodide Treatment: From Molecular Aspects to the Clinical View
by: Antonio De la Vieja, et al.
Published: (2021-02-01)

Targeting IGF2BP2 Promotes Differentiation of Radioiodine Refractory Papillary Thyroid Cancer via Destabilizing RUNX2 mRNA
by: Ri Sa, et al.
Published: (2022-03-01)

Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies
by: Mohamed Aashiq, et al.
Published: (2019-09-01)

Radioactive Iodine Therapy and Glucose Tolerance
by: Roghaieh Samadi, et al.
Published: (2017-04-01)

Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells
by: Honglai Zhang, et al.
Published: (2018-10-01)

Tracking dendritic cell migration into lymph nodes by using a novel PET probe 18F-tetrafluoroborate for sodium/iodide symporter
by: Sang Bong Lee, et al.
Published: (2017-04-01)

Bisphenol A increases hydrogen peroxide generation by thyrocytes both in vivo and in vitro
by: Maurício Martins da Silva, et al.
Published: (2018-10-01)

FOXA1 Regulation Turns Benzamide HDACi Treatment Effect-Specific in BC, Promoting NIS Gene-Mediated Targeted Radioiodine Therapy
by: Maitreyi Rathod, et al.
Published: (2020-12-01)

Cancer gene therapy: Prospects of using human sodium iodide symporter gene in non-thyroidal cancer
by: Shruti Dutta, et al.
Published: (2015-01-01)

Expression of pendrin and NIS iodide transporters in human breast tumor and peri-tumoral tissue
by: Katarzyna D. Arczewska, et al.
Published: (2019-11-01)

Visualizing mast cell migration to tumor sites using sodium iodide symporter of nuclear medicine reporter gene
by: Seul-Gi Oh, et al.
Published: (2023-09-01)

Progress in gene therapy for prostate cancer
by: Kamran Ali Ahmed, et al.
Published: (2012-11-01)

Tumor microenvironment affects exogenous sodium/iodide symporter expression
by: Fabio Castillo-Rivera, et al.
Published: (2021-01-01)

Analysis of the T354P mutation of the sodium/iodide cotransporter gene in children with congenital hypothyroidism due to dyshormonogenesis
by: Hajar Miranzadeh-Mahabadi, et al.
Published: (2016-01-01)

Downregulation of miR-146b-3p Inhibits Proliferation and Migration and Modulates the Expression and Location of Sodium/Iodide Symporter in Dedifferentiated Thyroid Cancer by Potentially Targeting MUC20
by: Shasha Hou, et al.
Published: (2021-01-01)

Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer
by: Hongxia Shang, et al.
Published: (2020-03-01)

An Inverse Agonist of Estrogen-Related Receptor Gamma, GSK5182, Enhances Na<sup>+</sup>/I<sup>−</sup> Symporter Function in Radioiodine-Refractory Papillary Thyroid Cancer Cells
by: Thoudam Debraj Singh, et al.
Published: (2023-02-01)

Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
by: Rebekka Spellerberg, et al.
Published: (2022-12-01)

Study on the Iodine 125 Uptake of H460 Lung Cancer Cell Line by Co-transfection with the Human Sodium/Iodide Symporter and the Human Thyroperoxidase
by: Wei LI, et al.
Published: (2010-06-01)